These results suggested that silencing SOX2‐OT inhibited NLRP3 expression by sponging miR‐2355‐3p, then inhibiting IL‐1β and TGF‐β1 expression and reducing ROS levels, resulting in alleviated cardiac dysfunction in rats with VA‐HF. The gene discussed is SOX2; the disease is hydrops fetalis.